Isolates of Klebsiella pneumoniae harbouring the carbapenemase KPC may have carbapenem MICs that remain in the susceptible range, and may therefore go unrecognized. To understand the mechanisms contributing to the variability in carbapenem MICs, 20 clinical isolates, all belonging to either of two clonal groups of KPC-possessing K. pneumoniae endemic to New York City, were examined. Expression of genes encoding KPC, the porins OmpK35 and OmpK36, and the efflux pump AcrAB was examined by real-time RT-PCR. Outer-membrane profiles of selected KPCproducing isolates were examined by SDS-PAGE, and proteins were identified by matrix-assisted laser desorption/ionization mass spectrometry. The identification of SHV and TEM b-lactamases and the genomic sequences of ompK35 and ompK36 were determined by PCR and DNA sequencing, respectively. For one clonal group, carbapenem MICs increased with decreasing expression of ompK36. A second clonal group also had carbapenem MICs that correlated with ompK36 expression. However, all of the isolates in this latter group continued to produce OmpK36, suggesting that porin configuration may affect entry of carbapenems. For isolates that had the greatest expression of ompK36, carbapenem MICs tended to be lower when determined by the broth microdilution technique, and scattered colonies were seen around the Etest zones of inhibition. All of the KPC-producing isolates were highly resistant to ertapenem, regardless of ompK36 expression. In conclusion, isolates of KPC-possessing K. pneumoniae that express ompK36 tend to have lower MICs to carbapenems and therefore may be more difficult to detect by clinical laboratories. Regardless of ompK36 expression, all of the KPC producers were consistently resistant to ertapenem.
INTRODUCTION
Klebsiella pneumoniae possessing the carbapenemase KPC is now widespread in many medical centres in the north-eastern USA and is being increasingly reported worldwide (Bratu et al., 2005a; Landman et al., 2007; Queenan & Bush, 2007) . The progressive spread of this b-lactamase, which is an efficient cephalosporinase and carbapenemase, can be partly explained by the difficulty clinical laboratories have in detecting isolates harbouring this enzyme. When carbapenem resistance is used as the gauge to identify KPC-possessing K. pneumoniae, a significant proportion will not be detected as they may have MICs that are below the breakpoint for resistance. In particular, automated systems may frequently misidentify these isolates as susceptible to carbapenems (Anderson et al., 2007; Bratu et al., 2005b; Tenover et al., 2006) . The reason for the variability in carbapenem MICs, particularly with imipenem and meropenem, is unknown.
It appears that there may be several factors besides carbapenemases that can contribute to carbapenem resistance in isolates of K. pneumoniae. Although unusual, K. pneumoniae lacking an efficient carbapenemase can still achieve resistance to carbapenems. These isolates typically possess an underlying extended-spectrum b-lactamase (ESBL) or AmpC-type b-lactamase (Bradford et al., 1997; Cao et al., 2000; Crowley et al., 2002) . In addition to a background of b-lactamase activity, alterations in porin production are an important contributor to carbapenem resistance. Many ESBL-carrying clinical isolates of K. pneumoniae lack OmpK35 (Hernández-Allés et al., 1999a), which augments resistance to ceftazidime (Doménech-Sánchez et al., 2003) . The additional loss of OmpK36 leads to reduced susceptibility to cefotaxime, cephamycins and carbapenems (Ardanuy et al., 1998; Crowley et al., 2002; Doménech-Sánchez et al., 2000 Martínez-Martínez et al., 1996 . Ertapenem may be particularly affected by the concomitant loss of OmpK35 and OmpK36 (Elliott et al., 2006; Jacoby et al., 2004; Mena et al., 2006; Woodford et al., 2007) . Porin loss has been correlated with disruption of ompK35 and ompK36 by insertions or deletions in some isolates (Cai et al., 2008; Hernández-Allés et al., 1999b; Kaczmarek et al., 2006; Mena et al., 2006) . In the small number of isolates of KPCproducing K. pneumoniae that have been studied, loss of OmpK35 (Woodford et al., 2004; Yigit et al., 2001) or OmpK36 (Cai et al., 2008) has been observed. Finally, the AcrAB efflux system has been shown to affect a wide range of antimicrobial agents, including tetracyclines, chloramphenicol, trimethoprim and fluoroquinolones (Nikaido, 1996) . Whether antibiotic efflux via this system is an important contributor to carbapenem resistance is unknown.
In this report, the mechanisms contributing to carbapenem resistance in clonal groups of KPC-possessing K. pneumoniae endemic to New York City were examined.
METHODS
Twenty clinical isolates of K. pneumoniae obtained from prior surveillance studies were chosen because they belong to important bla KPC -possessing ribotypes endemic to our region (Bratu et al., 2005a, b; Landman et al., 2007) . Susceptibility testing was performed using the Etest method (AB Biodisk); for isolates possessing bla KPC , susceptibility testing for the carbapenems was also performed using the broth microdilution method (CLSI, 2006) . For isolates possessing bla KPC , carbapenem hydrolysis of crude cell extracts in 100 mM phosphate buffer was measured spectrophotometrically, as described previously (Woodford et al., 2004 ). Student's t-test was used to compare hydrolysis rates between isolates; a two-tailed P value of ¡0.05 was considered significant. DNA amplification studies. To identify conserved regions, genetic sequences for a ribosomal housekeeping gene and for the target genes ompK35, ompK36 and acrB were amplified and sequenced using the primers described in Table 1 . DNA sequencing was performed using an automated fluorescent dye terminator sequencing system (Applied Biosystems) and analysed using BLAST. Plasmids were isolated by the alkaline lysis method (Sambrook & Russell, 2001) . Plasmids were transformed into One Shot TOP10 Electrocomp Escherichia coli (Invitrogen) by electroporation. Plasmid DNA from the transformants was then screened for the presence of TEM, SHV and KPC blactamases, and identified using previously established primers and conditions (Bratu et al., 2005a; Paterson et al., 2003) . Selected isolates were also examined for the presence of ACT-1 (Bradford et al., 1997) .
RT-PCR studies. Isolates were examined by real-time RT-PCR for expression of ompK35, ompK36, bla KPC and acrB. DNase-treated RNA was obtained from late-exponential-phase cultures using an RNeasy kit (Qiagen), and 25 ng RNA was used for each sample. Primer and probe concentrations were adjusted to achieve efficiencies of 90-110 % and all experiments were performed in triplicate. The primers and probes used in these experiments are given in Table 1 . Expression of each gene was normalized to that of a ribosomal housekeeping gene (rrsA). The relative expression of ompK35 and ompK36 was then calibrated against the corresponding expression by K. pneumoniae ATCC 13883 (an isolate with known expression of both porins). 
Expression of acrB was calibrated against a susceptible control isolate, K. pneumoniae ATCC 11296. Expression of bla KPC was initially calibrated against a previously described transformant possessing a plasmid with bla KPC-2 (Bratu et al., 2007) ; the clinical isolate of K. pneumoniae with the lowest expression was then considered the control. For all controls, relative expression was equal to 1.0.
Isolation and characterization of outer-membrane proteins.
Selected isolates had their outer-membrane proteins analysed by SDS-PAGE using standard techniques (Albertí et al., 1995; Hernández-Allés et al., 1999a) . Briefly, isolates were grown in nutrient broth, sonicated and centrifuged. Cell membranes were obtained following centrifugation at 100 000 g, and extracted with 1 % N-lauroylsarcosine. Protein concentrations were measured using the Bradford method, and each well contained~4 mg total protein. Samples were boiled in Laemmli's sample buffer. SDS-PAGE was performed with a 10 % acrylamide gel, which was then stained with Coomassie blue, and selected proteins were identified using matrix-assisted laser desorption/ionization (MALDI) MS. Peptide sequences were compared with published outer-membrane proteins of K. pneumoniae.
RESULTS AND DISCUSSION
Isolates belonging to clonal group A Eleven isolates belonged to clonal group A, a strain responsible for~85 % of bla KPC -possessing isolates in our region (Bratu et al., 2005a) . Five isolates did not harbour bla KPC but did have ESBLs (either bla SHV-12 -like or bla SHV-11 -like) and had reduced susceptibility to ceftazidime ( Table 2 ). The discrepancy in cephalosporin susceptibility for isolates CI504 and CI505 could not be explained by the information gathered from each isolate. All five had reduced expression of ompK35, and DNA sequencing revealed a frameshift mutation in this gene. All five expressed ompK36 and, consistent with other reports, remained susceptible to cefoxitin and carbapenems (Ardanuy et al., 1998; Crowley et al., 2002; Doménech-Sánchez et al., 2000 Martínez-Martínez et al., 1996) . Six isolates in this clonal group possessed bla KPC-2 (along with other b-lactamases). Despite variable expression of ompK35, all of these isolates possessed the same frameshift mutation, and OmpK35 was not evident by SDS-PAGE ( Fig. 1) and MALDI MS. DNA sequencing revealed that the ompK36 gene in this group was closely related to that found in the published genome of isolate MGH 78578. Expression of ompK36 was variable in these six isolates and correlated with findings by SDS-PAGE (Fig. 1) . Isolates with evidence of OmpK36 production had lower MICs to imipenem when determined by broth microdilution (Table 2 ) and had scattered colonies within the Etest zone of inhibition (Fig. 2a) . All six were resistant to meropenem and ertapenem (Table 2) . Expression of acrB did not correlate with the MICs of the carbapenems (data not shown).
Isolates belonging to clonal group B
Nine isolates belonged to clonal group B, a second important bla KPC -possessing strain in our region (Bratu et al., 2005a) . Four ESBL-possessing isolates (lacking bla KPC ) expressed ompK36 and remained susceptible to cefoxitin (and resistant to ceftazidime; Table 2 ). Five isolates possessed bla KPC-2 . Although most had evidence of transcription of ompK35 by real-time RT-PCR, production of OmpK35 was not evident by SDS-PAGE (Fig. 1) , suggesting post-transcriptional events affecting this porin. All of the isolates in this group had ample expression of ompK36, and this was also evident by SDS-PAGE (Fig. 1 ). Except for a 2 aa insertion (Gly-Asp) in the region of loop 3 of the porin, OmpK36 for isolates in this group was similar to that found in the susceptible control, K. pneumoniae ATCC 13883. Compared with OmpK36 found in clonal A group, the protein in this group had a 7 aa insert in the loop 6 region of the porin (in addition to several amino acid substitutions). Despite production of OmpK36 in these five isolates with bla KPC , it is noteworthy that decreasing expression of ompK36 still affected the broth microdilution MICs and Etest zones of inhibition of imipenem (Table 2, Fig. 2b ). It appears that, despite OmpK36 production in this group, subtle quantitative or qualitative changes in the porin affected entry of b-lactams. It is also noteworthy that the meropenem, ertapenem and cefoxitin MICs in the group B isolates lacking bla KPC were higher than those seen in the comparable group A isolates. Therefore, it appears that the OmpK36 phenotype in the group B isolates affected entry of b-lactams. Finally, the expression of acrB did not correlate with carbapenem resistance for isolates in this group (data not shown).
There appeared to be interplay between expression of bla KPC and ompK36 that affected the MICs to imipenem. Compared with isolate WO822, isolates CI513 and CI839, which had greater expression of bla KPC and ompK36, had substantially higher imipenem MICs (Fig. 2b) Expression of ompK35 and ompK36 was also assessed in four unrelated cephalosporin-susceptible clinical isolates. Compared with the control strain, K. pneumoniae ATCC 13883, expression of ompK35 was similar (mean 1.9 times the control, range 0.43-4.4) in these susceptible isolates. However, expression of ompK36 was increased compared with the control isolate (mean 4.4 times the control, range 2.0-5.4). Therefore, although K. pneumoniae ATCC 13883 is frequently used as a control in studies examining outermembrane proteins, expression of the genes encoding the porins in this isolate is reduced compared with wild-type clinical isolates.
The rapid and, in some regions, unabated spread of K. pneumoniae with KPC b-lactamases has been especially troubling. Clinical laboratories have relied on carbapenem susceptibility to identify pathogens harbouring these enzymes; however, it has been well documented that many isolates with KPC b-lactamases will have MICs of carbapenems below the CLSI-defined breakpoint for susceptibility (Anderson et al., 2007; Bratu et al., 2005b; Tenover et al., 2006) . In this report, involving important nosocomial strains of K. pneumoniae endemic to New York City, the MICs of carbapenems were found to be dependent on an interaction between the presence of bla KPC and expression of ompK36. It was also apparent that the OmpK36 phenotype may influence susceptibility. Isolates that abundantly expressed ompK36 tended to have lower imipenem MICs by the broth microdilution method and had scattered colonies within the Etest zone of inhibition. Consistent with other reports, the MICs of ertapenem were consistently higher than those of imipenem and meropenem for the isolates possessing bla KPC (Anderson et al., 2007; Bratu et al., 2005b) . Isolates that had MICs of imipenem and meropenem in the susceptible or intermediate range continued to be frankly resistant to ertapenem. As all of our examined isolates had either diminished or defective production of OmpK35 (typical of many ESBL-possessing strains), the contribution of this porin to resistance involving ertapenem cannot be assessed in this report. However, prior studies have not found this porin to be important for the development of carbapenem resistance (Hernández-Allés et al., 1999a) . Other studies have found that restoring OmpK36 and OmpK37 improved susceptibility to ertapenem in KPC-producing isolates of K. pneumoniae (Jacoby et al., 2004) . However, OmpK37 is often not expressed (Doménech-Sánchez et al., 1999) , and its role in carbapenem resistance in clinical isolates is unknown.
Although cephamycins retain activity against many ESBLproducing isolates of K. pneumoniae, they are often not recommended as therapeutic agents due to the development of resistance (secondary to diminished OmpK36 production). A similar caution should be exercised for KPCproducing isolates that appear susceptible to imipenem or meropenem, as downregulation of ompK36 expression will adversely affect the MICs to the carbapenems.
